1. Home
  2. PEP vs NVS Comparison

PEP vs NVS Comparison

Compare PEP & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PepsiCo Inc.

PEP

PepsiCo Inc.

HOLD

Current Price

$140.60

Market Cap

193.4B

ML Signal

HOLD

Logo Novartis AG

NVS

Novartis AG

HOLD

Current Price

$146.65

Market Cap

286.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PEP
NVS
Founded
1898
1895
Country
United States
Switzerland
Employees
N/A
75267
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
193.4B
286.5B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
PEP
NVS
Price
$140.60
$146.65
Analyst Decision
Buy
Hold
Analyst Count
14
5
Target Price
$166.79
$144.00
AVG Volume (30 Days)
6.7M
1.5M
Earning Date
04-16-2026
04-28-2026
Dividend Yield
3.66%
2.16%
EPS Growth
N/A
N/A
EPS
1.70
N/A
Revenue
$93,925,000,000.00
N/A
Revenue This Year
$5.78
$2.30
Revenue Next Year
$3.20
$5.27
P/E Ratio
$82.78
$23.13
Revenue Growth
2.25
N/A
52 Week Low
$127.60
$112.34
52 Week High
$171.48
$170.46

Technical Indicators

Market Signals
Indicator
PEP
NVS
Relative Strength Index (RSI) 31.67 45.57
Support Level $139.22 $145.30
Resistance Level $143.42 $157.63
Average True Range (ATR) 3.04 1.98
MACD -0.45 -0.24
Stochastic Oscillator 10.74 41.52

Price Performance

Historical Comparison
PEP
NVS

About PEP PepsiCo Inc.

PepsiCo is a global leader in snacks and beverages, owning well-known household brands including Pepsi, Mountain Dew, Gatorade, Lay's, Cheetos, and Doritos, among others. The company dominates the global savory snacks market and also ranks as the second-largest beverage provider in the world (behind Coca-Cola) with diversified exposure to carbonated soft drinks, or CSD, as well as water, sports, and energy drink offerings. Convenience foods account for approximately 58% of its total revenue, with beverages making up the rest. Pepsi owns the bulk of its manufacturing and distribution capacity in the US, but uses bottlers overseas for beverages. International markets made up 41% of total sales and 46% of operating profits before corporate expenses in 2025.

About NVS Novartis AG

Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.

Share on Social Networks: